Relationship between cellular immunity and myocardial enzymogram and cardiac function in patients with rheumatic heart disease after heart valve replacement
ZHANG Liang, ZHANG Cheng-xin, GE Sheng-lin
Author information+
Department of Cardiovascular Surgery, the First Affiliated Hospital of Anhui Medical University, Hefei 230022, China
To investigate the relationship between cellular immunity and myocardial enzymogram and cardiac function of patients with rheumatic heart disease after heart valve replacement, 52 patients with rheumatic heart disease who underwent heart valve replacement were selected in this study. The results showed that lymphocyte percentage and CD4+/CD8+ were decreased on day 1 post-operation (P < 0.05), and gradually recovered on day 7 and 14 (P < 0.05). Myocardial enzymogram [creatine kinase(CK), creatine kinase isoenzyme-MB(CK-MB),lactate dehydrogenase(LDH),α-hydroxybutyrate dehydrogenase(α-HBD), aspartate transaminase(AST)] was increased on day 1 post-operation (P < 0.05), and decreased gradually 7 and 14 days later (P < 0.05). Cardiac function [ejection fraction(EF), fractional shortening(FS)] decreased on day 1 post- operation (P < 0.05), and EF increased gradually on day 7 and 14 (P < 0.05). FS on day 14 was higher than that on day 1 (P < 0.05). Pearson correlation analysis showed that lymphocyte percentage, CD4+/CD8+ were negatively correlated with CK, CK-MB, LDH, α-HBD and AST levels at different time after operation (P < 0.05), while CD4+/CD8+ was positively correlated with EF and FS levels at different time after operation (P < 0.05). These results suggest that the cellular immune function of patients with rheumatic heart disease in perioperative period of heart valve replacement should be improved in order to improve the myocardial enzymogram and alleviate the damage of cardiac function.
ZHANG Liang, ZHANG Cheng-xin, GE Sheng-lin.
Relationship between cellular immunity and myocardial enzymogram and cardiac function in patients with rheumatic heart disease after heart valve replacement. Current Immunology. 2020, 40(4): 311-315